Praxis Precision Medicines Inc (NASDAQ: PRAX) is 138.55% higher on its value in year-to-date trading and has touched a low of $13.01 and a high of $67.21 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PRAX stock was last observed hovering at around $53.04 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $53.15, the stock is 1.16% and 5.66% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.18 million and changing 0.21% at the moment leaves the stock 24.68% off its SMA200. PRAX registered 154.92% gain for a year compared to 6-month gain of 7.29%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -6.67% loss in the last 1 month and extending the period to 3 months gives it a 11.99%, and is 5.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.75% over the week and 5.89% over the month.
Praxis Precision Medicines Inc (PRAX) has around 82 employees, a market worth around $943.94M and $1.77M in sales. Profit margin for the company is -6987.01%. Distance from 52-week low is 308.69% and -20.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-29.47%).
The EPS is expected to grow by 55.60% this year.
Praxis Precision Medicines Inc (PRAX) Top Institutional Holders
150.0 institutions hold shares in Praxis Precision Medicines Inc (PRAX), with institutional investors hold 104.22% of the company’s shares. The shares outstanding are 17.76M, and float is at 16.35M with Short Float at 11.38%. Institutions hold 103.95% of the Float.
Praxis Precision Medicines Inc (PRAX) Insider Activity
The most recent transaction is an insider purchase by DeSimone Jill,the company’sDirector. SEC filings show that DeSimone Jill bought 14,500 shares of the company’s common stock on Oct 05 ’23 at a price of $1.75 per share for a total of $25375.0. Following the purchase, the insider now owns 14500.0 shares.
